Small nerve fibres, small hands and small feet: a new syndrome of pain, dysautonomia and acromesomelia in a kindred with a novel NaV1.7 mutation

被引:62
|
作者
Hoeijmakers, Janneke G. J. [1 ]
Han, Chongyang [2 ,3 ]
Merkies, Ingemar S. J. [1 ,4 ]
Macala, Lawrence J. [2 ,3 ]
Lauria, Giuseppe [5 ]
Gerrits, Monique M. [6 ]
Dib-Hajj, Sulayman D. [2 ,3 ]
Faber, Catharina G. [1 ]
Waxman, Stephen G. [2 ,3 ]
机构
[1] Univ Med Ctr Maastricht, Dept Neurol, NL-6202 AZ Maastricht, Netherlands
[2] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA
[3] Vet Adm Med Ctr, Ctr Neurosci & Regenerat Res, West Haven, CT 06516 USA
[4] Spaarne Hosp, Dept Neurol, NL-2130 AT Hoofddorp, Netherlands
[5] IRCCS Fdn, Neuromuscular Dis Unit, I-20133 Milan, Italy
[6] Univ Med Ctr Maastricht, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands
关键词
small nerve fibre neuropathy; small fibre neuropathy; SCN9A mutation; acromesomelia; neuropathic pain; sodium channel; OF-FUNCTION MUTATION; CNS WHITE-MATTER; RAT OPTIC-NERVE; SODIUM-CHANNELS; IMMUNOREACTIVE NERVES; DIAGNOSTIC-CRITERIA; AXONAL PROTECTION; SCN9A MUTATIONS; SENSORY NEURONS; SKELETAL PAIN;
D O I
10.1093/brain/awr349
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The Na(V)1.7 sodium channel is preferentially expressed within dorsal root ganglion and sympathetic ganglion neurons and their small-diameter peripheral axons. Gain-of-function variants of Na(V)1.7 have recently been described in patients with painful small fibre neuropathy and no other apparent cause. Here, we describe a novel syndrome of pain, dysautonomia, small hands and small feet in a kindred carrying a novel Na(V)1.7 mutation. A 35-year-old male presented with erythema and burning pain in the hands since early childhood, later disseminating to the feet, cheeks and ears. He also experienced progressive muscle cramps, profound sweating, bowel disturbances (diarrhoea or constipation), episodic dry eyes and mouth, hot flashes, and erectile dysfunction. Neurological examination was normal. Physical examination was remarkable in revealing small hands and feet (acromesomelia). Blood examination and nerve conduction studies were unremarkable. Intra-epidermal nerve fibre density was significantly reduced compared to age- and sex-matched normative values. The patient's brother and father reported similar complaints including distal extremity redness and pain, and demonstrated comparable distal limb under-development. Quantitative sensory testing revealed impaired warmth sensation in the proband, father and brother. Genetic analysis revealed a novel missense mutation in the SCN9A gene encoding sodium channel Na(V)1.7 (G856D; c.2567G > A) in all three affected subjects, but not in unaffected family members. Functional analysis demonstrated that the mutation hyperpolarizes (-9.3 mV) channel activation, depolarizes (+6.2 mV) steady-state fast-inactivation, slows deactivation and enhances persistent current and the response to slow ramp stimuli by 10- to 11-fold compared with wild-type Na(V)1.7 channels. Current-clamp analysis of dorsal root ganglion neurons transfected with G856D mutant channels demonstrated depolarized resting potential, reduced current threshold, increased repetitive firing in response to suprathreshold stimulation and increased spontaneous firing. Our results demonstrate that the G856D mutation produces DRG neuron hyperexcitability which underlies pain in this kindred, and suggest that small peripheral nerve fibre dysfunction due to this mutation may have contributed to distal limb under-development in this novel syndrome.
引用
收藏
页码:345 / 358
页数:14
相关论文
共 14 条
  • [1] Infrequent NaV1.7 Mutation in Insensitivity to Pain, Erythromelalgia and Small Fiber Neuropathy
    Klein, Christopher J.
    Kilfoyle, Dean H.
    Wu, Yanhong
    Sandroni, Paola
    Low, Phillip A.
    Davis, Mark D.
    Dyck, Peter J.
    ANNALS OF NEUROLOGY, 2012, 72 : S23 - S23
  • [2] Strategic advances in the identification of small molecule inhibitors of NaV1.7 for the treatment of chronic pain
    Milgram, Benjamin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [3] The small fiber neuropathy NaV1.7 I228M mutation: impaired neurite integrity via bioenergetic and mitotoxic mechanisms, and protection by dexpramipexole
    Lee, Seong-il
    Hoeijmakers, Janneke G. J.
    Faber, Catharina G.
    Merkies, Ingemar S. J.
    Lauria, Giuseppe
    Waxman, Stephen G.
    JOURNAL OF NEUROPHYSIOLOGY, 2020, 123 (02) : 645 - 657
  • [4] Reversal of Peripheral Neuropathic Pain by the Small-Molecule Natural Product Narirutin via Block of Nav1.7 Voltage-Gated Sodium Channel
    Yang, Haoyi
    Shan, Zhiming
    Guo, Weijie
    Wang, Yuwei
    Cai, Shuxian
    Li, Fuyi
    Huang, Qiaojie
    Liu, Jessica Aijia
    Cheung, Chi Wai
    Cai, Song
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [5] Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in chronic constriction injury (CCI) rats
    Li, Jiahe
    Stratton, Harrison J.
    Lorca, Sabina A.
    Grace, Peter M.
    Khanna, Rajesh
    CHANNELS, 2022, 16 (01) : 1 - 8
  • [6] A RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY, SAFETY, AND TOLERABILITY OF LACOSAMIDE IN PATIENTS WITH GAIN-OF-FUNCTION NAV1.7 MUTATION-RELATED SMALL FIBER NEUROPATHY: THE LENSS STUDY
    de Greef, B. T. A.
    Geerts, M.
    Faber, C. G.
    Merkies, I. S. J.
    Hoeijmakers, J. G. J.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 268 - 268
  • [7] Small molecule targeting NaV1.7 via inhibition of CRMP2-Ubc9 interaction reduces pain-related outcomes in a rodent osteoarthritic model
    Hestehave, Sara
    Allen, Heather N.
    Gomez, Kimberly
    Duran, Paz
    Calderon-Rivera, Aida
    Loya-Lopez, Santiago
    Rodriguez-Palma, Erick J.
    Khanna, Rajesh
    PAIN, 2025, 166 (01) : 99 - 111
  • [8] Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain
    Braden, Kathryn
    Stratton, Harrison J.
    Salvemini, Daniela
    Khanna, Rajesh
    NEUROBIOLOGY OF PAIN, 2022, 11
  • [9] Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial–the LENSS study
    Bianca T. A. de Greef
    Ingemar S. J. Merkies
    Margot Geerts
    Catharina G. Faber
    Janneke G. J. Hoeijmakers
    Trials, 17
  • [10] Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study
    de Greef, Bianca T. A.
    Merkies, Ingemar S. J.
    Geerts, Margot
    Faber, Catharina G.
    Hoeijmakers, Janneke G. J.
    TRIALS, 2016, 17